AI brief of an SEC Form 8-K · Science Applications Intl (SAIC)

SAIC cuts FY2027 revenue guidance to $7.0B-$7.2B after recompete losses

Mixed Impact 4 of 5 guidance Written later

SAIC reported preliminary unaudited results for fiscal 2026 and cut its fiscal 2027 revenue guidance to $7.0 billion-$7.2 billion from $7.35 billion-$7.55 billion, now expecting an organic revenue decline of 2% to 4%. The company cited two unfavorable recompete award decisions and procurement delays. FY2026 adjusted EBITDA and adjusted diluted EPS came in above prior expectations, but revenue was modestly below, and FY2027 adjusted EBITDA guidance was lowered.

Key points

  • FY2026 revenue of about $7.26 billion, versus prior guidance of $7.275 billion-$7.325 billion; adjusted EBITDA of about $705 million, versus prior about $695 million
  • FY2026 adjusted diluted EPS of $10.40-$10.60, versus prior $9.80-$10.00; free cash flow of $570 million-$575 million, versus prior above $550 million
  • FY2027 adjusted EBITDA guidance of $705 million-$715 million, down from $725 million-$735 million; adjusted EBITDA margin raised to 9.9%-10.1% from 9.7%-9.9%
  • Full fourth quarter and fiscal 2026 results are scheduled for March 16, 2026, before market open; CFO Prabu Natarajan presents at the TD Cowen conference on February 11, 2026 at 4:20 PM ET

The filing

CompanyScience Applications Intl (SAIC)
Form8-K, current report
Filed with the SECFeb 11, 2026, 6:55 AM ET
Accession number0001571123-26-000008

Items reported: 2.02 Results of Operations7.01 Regulation FD Disclosure

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 12:59 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on February 11, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.